Electrolyte abnormalities and progressive renal failure in a cancer patient

Kidney Int. 2007 Jun;71(11):1181-4. doi: 10.1038/sj.ki.5002182. Epub 2007 Feb 28.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents, Alkylating / toxicity
  • Biopsy
  • Creatinine / blood
  • Deoxycytidine / analogs & derivatives
  • Deoxycytidine / therapeutic use
  • Diagnosis, Differential
  • Disease Progression
  • Docetaxel
  • Drug Administration Schedule
  • Fibrosarcoma / complications*
  • Fibrosarcoma / diagnosis*
  • Fibrosarcoma / drug therapy
  • Fibrosarcoma / pathology
  • Follow-Up Studies
  • Gastrointestinal Stromal Tumors / diagnosis*
  • Gastrointestinal Stromal Tumors / drug therapy
  • Gastrointestinal Stromal Tumors / pathology
  • Gemcitabine
  • Humans
  • Ifosfamide / toxicity
  • Inflammation / pathology
  • Kidney / surgery
  • Kidney Glomerulus / cytology
  • Kidney Glomerulus / ultrastructure
  • Kidney Tubules / pathology
  • Male
  • Middle Aged
  • Renal Insufficiency / metabolism*
  • Taxoids / therapeutic use
  • Treatment Outcome
  • Water-Electrolyte Imbalance / blood
  • Water-Electrolyte Imbalance / complications*

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Antineoplastic Agents, Alkylating
  • Taxoids
  • Deoxycytidine
  • Docetaxel
  • Creatinine
  • Ifosfamide
  • Gemcitabine